EP 2490673 A2 20120829 - AMORPHOUS ROTIGOTINE CO-PRECIPITATES
Title (en)
AMORPHOUS ROTIGOTINE CO-PRECIPITATES
Title (de)
AMORPHE ROTIGOTIN-COPRÄZIPITATE
Title (fr)
CO-PRÉCIPITÉS DE ROTIGOTINE AMORPHES
Publication
Application
Priority
- IN 2527CH2009 A 20091019
- IB 2010002844 W 20101018
Abstract (en)
[origin: WO2011048491A2] Disclosed herein is a stable amorphous co -precipitate of (-)-(S)-5-hydroxy-2-[N-n- propyl-N-2-(2-thienyl)ethylamino]tetralin (Rotigotine) with pharmaceutically acceptable excipients, methods for the preparation, pharmaceutical compositions, and methods of treating thereof. Advantageously, the amorphous co-precipitates of rotigotine have improved physio chemical characteristics that assist in their effective bioavailability.
IPC 8 full level
A61K 9/14 (2006.01); A61K 31/381 (2006.01)
CPC (source: EP)
A61K 9/146 (2013.01); A61K 31/381 (2013.01)
Citation (search report)
See references of WO 2011048491A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2011048491 A2 20110428; WO 2011048491 A3 20111229; EP 2490673 A2 20120829
DOCDB simple family (application)
IB 2010002844 W 20101018; EP 10784574 A 20101018